Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

SHA:688273 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	245.68	816.45	461.56	991.63	1,176	272.62
Trading Asset Securities	465.94	-	433.42	105.65	40	-
Cash & Short-Term Investments	711.62	816.45	894.98	1,097	1,216	272.62
Cash Growth	-12.19%	-8.77%	-18.44%	-9.75%	345.98%	81.97%
Accounts Receivable	38.39	27.91	17.79	11.41	26.84	10.18
Other Receivables	1.51	0.74	1.16	1.47	1.46	0.3
Receivables	39.9	28.66	18.94	12.88	28.3	10.48
Inventory	71.17	71.99	73.05	55.02	68.59	38.49
Prepaid Expenses	-	0.11	0.16	-	-	-
Other Current Assets	20.77	13.61	14.52	6.67	7.9	19.69
Total Current Assets	843.46	930.81	1,002	1,172	1,321	341.28
Property, Plant & Equipment	477.18	470.73	327.42	207.59	154.73	123.82
Long-Term Investments	184.23	100.08	98.73	79.7	0.56	0.44
Goodwill	0.24	41.23	41.9	0.91	0.91	0.91
Other Intangible Assets	23.05	49.57	55.61	31.21	18.5	7.19
Long-Term Deferred Tax Assets	16.28	17.93	9.49	9.99	6.14	6.47
Long-Term Deferred Charges	18.9	17.54	8.13	5.27	6.59	8.03
Other Long-Term Assets	1.42	1.38	3.69	27.4	3.88	0.59
Total Assets	1,565	1,629	1,547	1,534	1,512	488.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	61.77	14.17	17.04	9.16	12.57	13.09
Accrued Expenses	12.87	33.97	37.65	23.97	26.6	32.64
Short-Term Debt	12.94	13.1	7.01	-	-	-
Current Portion of Leases	-	3.84	2.94	6.13	1.44	2.12
Current Income Taxes Payable	7.32	1.14	0.68	3.45	9.26	5.12
Current Unearned Revenue	29.91	51.61	51.27	45.66	47.98	33.3
Other Current Liabilities	20.34	102.94	46.38	44.86	25.7	13.85
Total Current Liabilities	148.12	220.78	162.96	133.24	123.55	100.11
Long-Term Leases	5.87	9.49	0.65	2.37	7.99	4.1
Long-Term Unearned Revenue	15.68	15.78	15.94	17.75	6.03	10.44
Long-Term Deferred Tax Liabilities	1.61	3.68	5.46	5.25	4.39	1.36
Other Long-Term Liabilities	-	9.94	14.64	-	-	-
Total Liabilities	171.28	259.67	199.66	158.6	141.96	116.01

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	100	100	100	100.62	100	75
Additional Paid-In Capital	1,005	984.66	984.54	999.45	982.7	92.55
Retained Earnings	322.24	314.07	279.91	276.8	267.48	195.95
Treasury Stock	-53.58	-53.58	-52.25	-31.09	-	-
Total Common Equity	1,374	1,345	1,312	1,346	1,350	363.5
Minority Interest	19.45	24.44	34.76	29.54	19.77	9.24
Shareholders' Equity	1,393	1,370	1,347	1,375	1,370	372.74
Total Liabilities & Equity	1,565	1,629	1,547	1,534	1,512	488.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	21.77	26.42	10.6	8.51	9.43	6.22
Net Cash (Debt)	689.85	790.03	884.38	1,089	1,206	266.4
Net Cash Growth	-13.11%	-10.67%	-18.77%	-9.75%	352.86%	86.98%
Net Cash Per Share	7.05	8.08	8.98	10.89	14.48	3.55
Filing Date Shares Outstanding	97.78	97.81	97.81	99.51	100	75
Total Common Shares Outstanding	97.78	97.81	97.86	100.62	100	75
Working Capital	695.35	710.03	838.7	1,039	1,197	241.17
Book Value Per Share	14.05	13.75	13.41	13.37	13.50	4.85
Tangible Book Value	1,351	1,254	1,215	1,314	1,331	355.4
Tangible Book Value Per Share	13.81	12.82	12.41	13.06	13.31	4.74
Buildings	-	348.78	112.1	112.1	112.1	112.1
Machinery	-	60.87	53.53	44.39	37.31	21.95
Construction In Progress	-	105.88	203	77.04	19.99	-

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error